MEI Pharma Chair Christine White to retire, not stand for reelection; board size to reduce to eight

Lite Strategy, Inc.

Dr. Christine A. White, Board Chair, will retire and not stand for reelection at fiscal 2023 annual meeting, ending 12+ years of service.
White will continue as Chair and director until the annual meeting; retirement not due to any disagreement with the company.
Board does not plan to appoint a new director; board size will decrease from nine to eight directors.
Successor Chair is under consideration but no formal decision has been made as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Christine A. White

Chair and member of the Board of Directors

LITS · Lite Strategy, Inc.

Filed: September 15, 2022, 7:59 PM ET

Dr. Christine A. White, Chair and member of the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) and member of the Nominating and Corporate Governance Committee of the Board (the “Committee”), informed the Company that, after more than 12 years of service, she has decided to formally retire and thus she does not intend to stand for reelection at the Company’s fiscal year 2023 annual meeting of stockholders (the “Annual Meeting”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Christine A. White departed as Chair and member of the Board of Directors at Lite Strategy, Inc..

Action: retire and not stand for reelection
Role: Chair and member of the Board of Directors

Exact text from the filing

Dr. Christine A. White, Chair and member of the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) and member of the Nominating and Corporate Governance Committee of the Board (the “Committee”), informed the Company that, after more than 12 years of service, she has decided to formally retire and thus she does not intend to stand for reelection at the Company’s fiscal year 2023 annual meeting of stockholders (the “Annual Meeting”).

View on SEC.gov

Lite Strategy, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-245651

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.